Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$479M |
| 2 |
Meta Platforms (Facebook)
META
|
+$465M |
| 3 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$445M |
| 4 |
Kenvue
KVUE
|
+$434M |
| 5 |
Micron Technology
MU
|
+$431M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$3.24B |
| 2 |
Apple
AAPL
|
+$1.9B |
| 3 |
Microsoft
MSFT
|
+$1.56B |
| 4 |
PepsiCo
PEP
|
+$1.34B |
| 5 |
JPMorgan Chase
JPM
|
+$1.34B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 43.54% |
| 2 | Technology | 19.7% |
| 3 | Financials | 7.47% |
| 4 | Consumer Discretionary | 6.7% |
| 5 | Communication Services | 6.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2026
Avient
AVNT
$3.78B
| $6.32M | ﹤0.01% |
202,227
-17,010
| -8% | -$526K |
2022 Q1
15 quarters
|
|
2027
Expro Ltd
XPRO
$1.83B
| $6.3M | ﹤0.01% |
472,047
-21,362
| -4% | -$288K |
2015 Q2
42 quarters
|
|
|
RAL
2028
Ralliant Corp
RAL
$8.1B
| $6.29M | ﹤0.01% |
123,464
+35,212
| +40% | +$1.65M |
2025 Q2
2 quarters
|
|
2029
Viavi Solutions
VIAV
$11.6B
| $6.26M | ﹤0.01% |
351,419
+23,395
| +7% | +$378K |
2013 Q2
50 quarters
|
|
2030
Patrick Industries
PATK
$2.16B
| $6.26M | ﹤0.01% |
57,753
+4,658
| +9% | +$489K |
2013 Q2
50 quarters
|
|
2031
Phinia Inc
PHIN
$2.19B
| $6.26M | ﹤0.01% |
99,847
+43,926
| +79% | +$2.43M |
2023 Q3
9 quarters
|
|
2032
Outfront Media
OUT
$5.06B
| $6.26M | ﹤0.01% |
259,647
-127,461
| -33% | -$2.65M |
2014 Q2
46 quarters
|
|
2033
Rush Enterprises Class A
RUSHA
$5.51B
| $6.24M | ﹤0.01% |
173,538
+21,412
| +14% | +$742K |
2016 Q2
38 quarters
|
|
2034
Ligand Pharmaceuticals
LGND
$6.04B
| $6.24M | ﹤0.01% |
32,982
+2,699
| +9% | +$519K |
2013 Q2
50 quarters
|
|
2035
Griffon
GFF
$4.26B
| $6.24M | ﹤0.01% |
84,668
+15,637
| +23% | +$1.16M |
2016 Q1
39 quarters
|
|
2036
Peabody Energy
BTU
$3.02B
| $6.24M | ﹤0.01% |
209,953
+17,297
| +9% | +$508K |
2017 Q2
34 quarters
|
|
2037
Mueller Water Products
MWA
$3.38B
| $6.23M | ﹤0.01% |
261,545
+37,008
| +16% | +$917K |
2016 Q2
38 quarters
|
|
2038
GitLab
GTLB
$8.29B
| $6.21M | ﹤0.01% |
165,584
+25,466
| +18% | +$1.1M |
2022 Q1
15 quarters
|
|
2039
Twist Bioscience
TWST
$12.5B
| $6.16M | ﹤0.01% |
194,071
-32,597
| -14% | -$1.02M |
2018 Q4
28 quarters
|
|
2040
Vornado Realty Trust
VNO
$6.3B
| $6.15M | ﹤0.01% |
184,763
-124,312
| -40% | -$4.54M |
2013 Q2
50 quarters
|
|
2041
CALL
Rigetti Computing
RGTI
$5.09B
| $6.15M | ﹤0.01% |
277,500
+276,600
| +30,733% | +$9.02M |
2025 Q3
1 quarter
|
|
2042
Renasant Corp
RNST
$3.65B
| $6.14M | ﹤0.01% |
174,353
+34,776
| +25% | +$1.23M |
2016 Q3
37 quarters
|
|
|
PR
2043
Permian Resources
PR
$18.5B
| $6.13M | ﹤0.01% |
436,621
-786,246
| -64% | -$10.6M |
2017 Q2
34 quarters
|
|
2044
CALL
Darling Ingredients
DAR
$9.93B
| $6.12M | ﹤0.01% |
170,000
-34,500
| -17% | -$1.17M |
2025 Q2
2 quarters
|
|
2045
Qorvo
QRVO
$10.1B
| $6.11M | ﹤0.01% |
72,329
-8,181
| -10% | -$722K |
2015 Q1
43 quarters
|
|
2046
Axcelis
ACLS
$4.56B
| $6.1M | ﹤0.01% |
75,982
+6,397
| +9% | +$536K |
2017 Q1
35 quarters
|
|
|
STUB
2047
CALL
StubHub Holdings
STUB
$2.07B
| $6.09M | ﹤0.01% |
+450,000
| New | +$7.07M |
2025 Q4
0 quarters
|
|
2048
Cushman & Wakefield Ltd
CWK
$2.8B
| $6.08M | ﹤0.01% |
375,253
+36,927
| +11% | +$585K |
2018 Q3
29 quarters
|
|
2049
LKQ Corp
LKQ
$5.77B
| $6.07M | ﹤0.01% |
201,088
-634,749
| -76% | -$19.1M |
2013 Q2
50 quarters
|
|
2050
Hilton Grand Vacations
HGV
$2.71B
| $6.07M | ﹤0.01% |
135,577
-2,541
| -2% | -$108K |
2022 Q1
15 quarters
|
|
Similar funds
Barclays's Q4 2025 Portfolio in Review
As of Q4 2025, Barclays held 5,847 positions worth $417B, down 9.7% from $461B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Barclays withdrew a net $23.5B in Q4 2025, closing 641 positions and reducing 1,714 holdings. Its most notable exit was Verona Pharma, an estimated $149M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 44% of assets, down from 44% a quarter earlier, followed by Technology and Financials.
Against the trend, Barclays opened a new position in The Magnum Ice Cream Company N.V. worth $156M.
- Barclays's largest Q4 2025 buy was The Magnum Ice Cream Company N.V.: 9,862,859 shares worth $156M.
- Barclays added most to Gilead Sciences in Q4 2025, an estimated $479M increase.
- Barclays's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $3.24B.
- Barclays fully exited Verona Pharma in Q4 2025, selling an estimated $149M.
- Barclays's ten largest holdings make up 35% of its $417B portfolio in Q4 2025.
- Barclays opened 403 new positions and closed 641 in Q4 2025.
- Barclays's portfolio value fell 9.7% quarter-over-quarter to $417B.
Based on Barclays's 13F filing for Q4 2025, filed 13 Feb 2026.